Immunohistochemistry (IHC) further demonstrated reduced ARPC1B expression and diminished Ki-67 staining in ARPC1B-silenced tumors, indicating decreased tumor cell proliferation (Fig. A6). Here, ARPC1B is linked to neoplasm.